Publications by authors named "Albert Mason"
Article Synopsis
- The study focuses on the VENTANA FOLR1 Assay, which detects the overexpression of folate receptor-α (FRα) in epithelial ovarian cancer, a key biomarker for targeted therapy.
- The assay demonstrates high reliability, with over 98% agreement in repeatability and a 98.4% staining acceptability rate during the SORAYA clinical trial, indicating its effectiveness in selecting patients for treatment.
- Findings show that the VENTANA FOLR1 Assay is a robust tool for identifying ovarian cancer patients who may benefit from treatment with mirvetuximab soravtansine (MIRV).
We report a case of transitional cell urethral cancer diagnosed 14 years after radical cystectomy. Traditionally, in the postcystectomy setting, these cancers have been referred to as 'recurrences'. We review the biological models for the oncogenesis of these cancers and propose that they are typically a result of a field cancerization effect, rather than being derived from the same clone responsible for the original urothelial tumor.
View Article and Find Full Text PDF